VistaGen Therapeutics, Inc. Business Finance Contracts & Agreements
71 Contracts & Agreements
- Escrow Agreements (1 contract)
- Exchange Agreements (3)
- Investor Rights Agreements (1)
- Joinder Agreements (1)
- Note Agreements (12)
- Purchase Agreements (8)
- Security Agreements (2)
- Stock Agreements (3)
- Subscription Agreements (5)
- Underwriting Agreements (8)
- Warrant Agreements (27)
- Form of T2 Warrant (Filed With SEC on October 4, 2023)
- Form of T1 Warrant (Filed With SEC on October 4, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on October 4, 2023)
- Underwriting Agreement, dated as of October 2, 2023, by and among the Company, Jefferies LLC, Stifel, Nicolaus & Company, Incorporated and William Blair & Company, L.L.C (Filed With SEC on October 4, 2023)
- Underwriting Agreement, dated December 18, 2020, by and among VistaGen Therapeutics, Inc., Jefferies LLC and William Blair & Company, L.L.C (Filed With SEC on December 22, 2020)
- Underwriting Agreement, dated August 2, 2020, by and between VistaGen Therapeutics, Inc. and Maxim Group LLC (Filed With SEC on August 6, 2020)
- Form of Warrant (Filed With SEC on January 27, 2020)
- Form of Securities Purchase Agreement, dated January 24, 2020, between the Company and each purchaser named in the signature pages thereto (Filed With SEC on January 27, 2020)
- Form of Subscription Agreement for Fall 2019 Private Placement (Filed With SEC on November 7, 2019)
- Underwriting Agreement, dated February 26, 2019, by and between VistaGen Therapeutics, Inc. and William Blair & Company, L.L.C (Filed With SEC on March 4, 2019)
- Form of Fall 2018 Private Placement Warrant (Filed With SEC on October 29, 2018)
- Form of Fall 2018 Private Placement Subscription Agreement (Filed With SEC on October 29, 2018)
- Form of 2018 Private Placement Warrant (Filed With SEC on August 9, 2018)
- Form of 2018 Private Placement Subscription Agreement (Filed With SEC on August 9, 2018)
- Form of Warrant (Filed With SEC on December 13, 2017)
- Underwriting Agreement, dated December 11, 2017 (Filed With SEC on December 13, 2017)
- Form of Warrant (Filed With SEC on December 7, 2017)
- Form of Underwriting Agreement (Filed With SEC on December 7, 2017)
- Form of Series A2 Warrant (Filed With SEC on August 31, 2017)
- Form of Series A1 Warrant (Filed With SEC on August 31, 2017)
- Underwriting Agreement, dated as of August 31, 2017,by and between VistaGen Therapeutics, Inc. and Oppenheimer & Co. Inc (Filed With SEC on August 31, 2017)
- VISTAGENTHERAPEUTICS, INC. AMENDEDAND RESTATED 2016STOCK INCENTIVE PLAN (formerly,the 2008 Stock Incentive Plan) (Filed With SEC on June 29, 2017)
- COMMON STOCK PURCHASE WARRANT VISTAGEN THERAPEUTICS, INC. (Filed With SEC on May 16, 2016)
- VISTAGEN THERAPEUTICS, INC. WARRANT AGENCY AGREEMENT (Filed With SEC on May 16, 2016)
- VISTAGEN THERAPEUTICS, INC. WARRANT AGENCY AGREEMENT (Filed With SEC on May 5, 2016)
- COMMON STOCK PURCHASE WARRANT VISTAGEN THERAPEUTICS, INC. (Filed With SEC on May 5, 2016)
- VistaGen Therapeutics, Inc. _____ shares of Common Stock Warrants to purchase up to [_____] shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 5, 2016)
- WARRANT EXCHANGE AGREEMENT (Filed With SEC on February 16, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 13, 2015)
- AMENDMENT NO. 1 TO AMENDED AND RESTATED NOTE CONVERSION AGREEMENT AND WARRANT AMENDMENT (Filed With SEC on September 4, 2014)
- FORM OF ESCROW DEPOSIT AGREEMENT (Filed With SEC on July 28, 2014)
- FORM OF WARRANT TO PURCHASE SHARES OF COMMON STOCK OF VISTAGEN THERAPEUTICS, INC. Expires August __, 201_ (Filed With SEC on July 28, 2014)
- Form of Subscription Agreement (Filed With SEC on July 28, 2014)
- AMENDED AND RESTATED NOTE CONVERSION AGREEMENT AND WARRANT AMENDMENT (Filed With SEC on July 22, 2014)
- WARRANT TO PURCHASE COMMON STOCK OF VISTAGEN THERAPEUTICS, INC. (Filed With SEC on June 25, 2014)
- PROMISSORY NOTE (Filed With SEC on June 25, 2014)
- AMENDMENT TO CONVERTIBLE PROMISSORY NOTE AND WARRANT (Filed With SEC on June 25, 2014)
- WARRANT TO PURCHASE COMMON STOCK OF VISTAGEN THERAPEUTICS, INC. (Filed With SEC on June 25, 2014)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on June 25, 2014)
- WARRANT TO PURCHASE SHARES OF COMMON STOCK OF VISTAGEN THERAPEUTICS, INC. Expires December 31, 2016 (Filed With SEC on April 8, 2014)
